Genky DrugStores Co., Ltd.

Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ(株)

9267.T

Pharmaceutical Retailers

2026/01/16 Updated

Market Cap: $837.2M (¥132.7B)

Stock Price: $27.54 (¥4,365)

Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated

18.90

PER (Price Earnings Ratio)

vs Industry Avg: +9.4

2.40

PBR (Price to Book Ratio)

vs Industry Avg: +1.1

0.30%

Dividend Yield

vs Industry Avg: -2.65%

Price Trend

2026/01/16 Updated

Short-term

5-Day MA

-2.09%

Near-term

25-Day MA

-10.81%

Mid-term

75-Day MA

-11.69%

Long-term

200-Day MA

+2.25%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥4,385

Open ¥4,345

High ¥4,395

Low ¥4,310

Close ¥4,365

TRADING

Volume 109,500

Average Volume 78,425

Turnover ¥5億

Min. Purchase ¥436,500

Analyst Recommendations 2 analysts

Updated 2026/01/11

Strong Buy

Buy

Hold

Sell

Strong Sell

Target Price (Mean)

¥5,700

Strong Buy

¥6,000

High

¥5,700

Median

¥5,400

Low

+13% vs Current Price

This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/01/11

47.7%

Insider Holdings

27.7%

Institutional

24.6%

Public Float

Institutional Holders

Insider Holdings 47.7%

Institutional 27.7%

Public Float 24.6%

Dividend History

Updated 2026/01/11

Dividend Yield

¥13

Annual Dividend

0.0%

YoY Growth

5.6%

Payout Ratio

Year	Dividend	Change
2025	¥13	0.0%
2024	¥13	+4.0%
2023	¥13	0.0%
2022	¥13	0.0%
2021	¥13	-

Financial Performance

2026/01/11 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

	2022	2023	2024	2025
Income Statement
Revenue	¥154,639M	¥169,059M	¥184,860M	¥200,786M
Gross Profit	¥30,954M	¥34,553M	¥37,620M	¥40,889M
Operating Income	¥5,675M	¥6,709M	¥9,015M	¥9,658M
Pretax Income	¥6,142M	¥6,774M	¥8,906M	¥10,118M
Net Income	¥4,420M	¥4,764M	¥6,324M	¥7,066M
EPS	¥145.44	¥156.79	¥207.94	¥232.04
Operating Margin	3.67%	3.97%	4.88%	4.81%
Balance Sheet
Total Assets	¥97,118M	¥105,912M	¥113,939M	¥127,326M
Total Equity	¥36,232M	¥40,680M	¥46,679M	¥53,427M
Total Liabilities	¥60,886M	¥65,232M	¥67,260M	¥73,899M
Cash	¥5,438M	¥5,329M	¥5,896M	¥6,221M
Interest-bearing Debt	¥30,959M	¥32,354M	¥30,648M	¥34,374M
Equity Ratio	37.31%	38.41%	40.97%	41.96%
D/E Ratio	0.85	0.80	0.66	0.64
Cash Flow
Operating CF	¥6,076M	¥8,773M	¥13,256M	¥12,597M
Investing CF	-¥10,588M	-¥9,736M	-¥10,631M	-¥15,618M
Financing CF	¥2,037M	¥854M	-¥2,058M	¥3,346M
Free CF	-¥4,430M	-¥1,155M	¥2,815M	-¥2,510M
Efficiency
ROE	12.20%	11.71%	13.55%	13.23%
ROA	4.55%	4.50%	5.55%	5.55%